From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action.

From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action.

Item
http://www.wikidata.org/entity/Q34391213
Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network AnalysisEditorial: Multi-omic data integrationVascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancerAberrant methylation patterns in colorectal cancer: a meta-analysis.Molecular disease presentation in diabetic nephropathy.Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine.The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease.The nephrologist of tomorrow: towards a kidney-omic future.Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus.Interaction networks for identifying coupled molecular processes in microbial communities.Precision medicine for managing diabetesMicroarray analysis reveals gene and microRNA signatures in diabetic kidney disease.Integrated powered density: Screening ultrahigh dimensional covariates with survival outcomes.
P2860

From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action.

Item
http://www.wikidata.org/entity/Q34391213
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
From molecular signatures to p ...... and drug mechanism of action.
@ast
From molecular signatures to p ...... and drug mechanism of action.
@en
From molecular signatures to p ...... and drug mechanism of action.
@nl
type
label
From molecular signatures to p ...... and drug mechanism of action.
@ast
From molecular signatures to p ...... and drug mechanism of action.
@en
From molecular signatures to p ...... and drug mechanism of action.
@nl
prefLabel
From molecular signatures to p ...... and drug mechanism of action.
@ast
From molecular signatures to p ...... and drug mechanism of action.
@en
From molecular signatures to p ...... and drug mechanism of action.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
From molecular signatures to p ...... and drug mechanism of action.
@en
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P921
P932